TrialOphthalmology2018

Phase II Randomized, Double-Masked, Vehicle-Controlled Trial of Recombinant Human Nerve Growth Factor for Neurotrophic Keratitis.

Stefano Bonini et al.PubMed ↗Publisher ↗

No numbers read from the abstract.